2021 Q3 Form 10-Q Financial Statement

#000149315221027278 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $1.553M $636.0K
YoY Change 144.24% 1.62%
Cost Of Revenue $335.6K $217.1K
YoY Change 54.56% -5.2%
Gross Profit $1.218M $418.9K
YoY Change 190.72% 5.56%
Gross Profit Margin 78.4% 65.86%
Selling, General & Admin $214.2K $192.4K
YoY Change 11.37% -24.65%
% of Gross Profit 17.59% 45.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $280.1K $236.1K
YoY Change 18.6% 12.59%
% of Gross Profit 23.0% 56.37%
Operating Expenses $501.5K $435.7K
YoY Change 15.11% -7.61%
Operating Profit $716.3K -$16.81K
YoY Change -4361.39% -77.52%
Interest Expense -$7.520K -$25.17K
YoY Change -70.12% 213.84%
% of Operating Profit -1.05%
Other Income/Expense, Net -$7.518K
YoY Change
Pretax Income $708.8K -$41.97K
YoY Change -1788.9% -49.31%
Income Tax
% Of Pretax Income
Net Earnings $708.8K -$41.97K
YoY Change -1788.9% -49.31%
Net Earnings / Revenue 45.63% -6.6%
Basic Earnings Per Share $0.34
Diluted Earnings Per Share $330.7K -$20.56K
COMMON SHARES
Basic Shares Outstanding 2.091M shares
Diluted Shares Outstanding 2.144M shares

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.57K $62.68K
YoY Change 49.28% -11.09%
Cash & Equivalents $93.57K $62.68K
Short-Term Investments
Other Short-Term Assets $43.24K $23.90K
YoY Change 80.92% -38.98%
Inventory
Prepaid Expenses
Receivables $791.2K $321.4K
Other Receivables $0.00 $0.00
Total Short-Term Assets $928.1K $407.9K
YoY Change 127.5% -11.09%
LONG-TERM ASSETS
Property, Plant & Equipment $9.991M $9.627M
YoY Change 3.79% 3.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $225.0K $175.0K
YoY Change 28.57% 75.0%
Other Assets $23.14K $40.00
YoY Change 57750.0% -99.85%
Total Long-Term Assets $10.24M $9.802M
YoY Change 4.46% 4.0%
TOTAL ASSETS
Total Short-Term Assets $928.1K $407.9K
Total Long-Term Assets $10.24M $9.802M
Total Assets $11.17M $10.21M
YoY Change 9.38% 3.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $129.9K $112.3K
YoY Change 15.66% -23.72%
Accrued Expenses $53.29K $54.91K
YoY Change -2.95% -15.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $183.2K $167.2K
YoY Change 9.55% -21.28%
LONG-TERM LIABILITIES
Long-Term Debt $1.212M
YoY Change 151.16%
Other Long-Term Liabilities $834.9K $770.2K
YoY Change 8.4% -12.47%
Total Long-Term Liabilities $0.00 $1.982M
YoY Change -100.0% 45.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.2K $167.2K
Total Long-Term Liabilities $0.00 $1.982M
Total Liabilities $1.018M $2.150M
YoY Change -52.64% 36.49%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.15M $8.060M
YoY Change
Total Liabilities & Shareholders Equity $11.17M $10.21M
YoY Change 9.38% 3.3%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $708.8K -$41.97K
YoY Change -1788.9% -49.31%
Depreciation, Depletion And Amortization $280.1K $236.1K
YoY Change 18.6% 12.59%
Cash From Operating Activities $918.8K $97.77K
YoY Change 839.73% -37.72%
INVESTING ACTIVITIES
Capital Expenditures -$354.3K -$458.6K
YoY Change -22.74% -13.01%
Acquisitions
YoY Change
Other Investing Activities $96.66K $116.6K
YoY Change -17.07% 33202.86%
Cash From Investing Activities -$257.7K -$342.1K
YoY Change -24.67% -35.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -648.3K 254.4K
YoY Change -354.78% -12.26%
NET CHANGE
Cash From Operating Activities 918.8K 97.77K
Cash From Investing Activities -257.7K -342.1K
Cash From Financing Activities -648.3K 254.4K
Net Change In Cash 12.82K 10.15K
YoY Change 26.31% -112.71%
FREE CASH FLOW
Cash From Operating Activities $918.8K $97.77K
Capital Expenditures -$354.3K -$458.6K
Free Cash Flow $1.273M $556.4K
YoY Change 128.82% -18.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
USD
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
shares
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
shares
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2020Q3 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
USD
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
25051 USD

Files In Submission

Name View Source Status
0001493152-21-027278-index-headers.html Edgar Link pending
0001493152-21-027278-index.html Edgar Link pending
0001493152-21-027278.txt Edgar Link pending
0001493152-21-027278-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
mxc-20210930.xsd Edgar Link pending
mxc-20210930_cal.xml Edgar Link unprocessable
mxc-20210930_def.xml Edgar Link unprocessable
mxc-20210930_lab.xml Edgar Link unprocessable
mxc-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending